Biomarkers and Depressive Symptoms in a Sample of Cognitively Intact and Alzheimer’s Disease Elderly Males


Serum-based biomarkers and GDS-30 score and subscales of depressive symptoms were examined in a cross-sectional sample of 81 elderly men drawn from the TARCC cohort. Measurements included neuropsychological assessment and serum. Thirty three patients met consensus diagnosis for probable AD and forty eight were cognitively intact. Although initial regression analysis of all subjects showed significant relationships between depression and specific biomarkers, analyses based on diagnosis indicated that none of the biomarkers were significantly associated with depression among the controls. Among AD males MIF was significantly associated with total GDS scores and subscales of dysphoria, meaninglessness, and cognitive impairment. TNF-α was significantly associated with the apathy in AD males. Higher levels of MIF were associated with less depression in AD men. TNF-α was positively associated with degree of apathy. This study suggests the importance of cognitive status, gender and subtypes of depression when investigating biomarkers and depression in the elderly.

Share and Cite:

J. Hall, H. Vo, L. Johnson, S. Winter, R. Barber and S. O’Bryant, "Biomarkers and Depressive Symptoms in a Sample of Cognitively Intact and Alzheimer’s Disease Elderly Males," Neuroscience and Medicine, Vol. 2 No. 4, 2011, pp. 306-312. doi: 10.4236/nm.2011.24040.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] P. Gudmundsson, I. Skoog, M. Waern, K. Blennow, S. Palsson, et al., “The Relationship between Cerebrospinal Fluid Biomarkers and Depression in Elderly Women,” American Journal of Geriatric Psychiatry, Vol. 15, No. 10, 2007, pp. 832-838. doi:10.1097/JGP.0b013e3180547091
[2] J. Wiltfang, P. Lewczuk, P. Riederer, et al., “Consensus Paper of the WFSBP Task Force on Biological Markers of Dementia: The Role of CSF and Blood Analysis in the Early and Differentia Diagnosis of Dementia,” World Journal of Biological Psychiatry, Vol. 6, No. 2, 2006, pp. 69-84. doi:10.1080/15622970510029786
[3] S. Palsson, L. Larsson, E. Tengelin, et al., “The Prevalence of Depression in Relation to Cerebral Atrophy and Cognitive Performance in 70- and 74-Year-Old Women in Gothenburg,” The Women’s Health Study. Psychological Medicine, Vol. 31, 2001, pp. 39-49.
[4] S. E. Starkstein, P. Gustavo, E. Chemerinski, et al., “Syndromic Validity of Apathy in Alzheimer’s Disease,” American Journal Psychiatry, Vol. 158, 2001, pp. 872- 877. doi:10.1176/appi.ajp.158.987.872
[5] G. S. Alexopoulos and S. S. Morimoto, “The Inflammation Hypothesis in Geriatric Depression,” International Journal of Geriatric Psychiatry, Vol. 26, No. 11, 2011, pp. 1109-1118.
[6] B. W. Penninx, S. B. Kritchevsky, K. Yaffe, et al., “Inflammatory Markers and Depressed Mood in Older Persons: Results from the Healthy, Aging and Body Composition Study,” Biological Psychiatry, Vol. 54, No. 5, 2003, pp. 566-572. doi:10.1016/S0006-3223(02)01811-5
[7] Y. Dowlati, N. Herrmann, W. Swardfager, et al., “A Meta-Analysis of Cytokines in Major Depression,” Biological Psychiatry, Vol. 67(5, 2010, pp. 446-457. doi:10.1016/j.biopsych.2009.09.033
[8] M. A. Bremmer, A. T. F. Beekman and D. J. H. Deeg, “Inflammatory Markers in Late-Life Depression: Results from a Population-Based Study,” Journal of Affective Disorders, Vol. 106, 2008, pp. 248-255. doi:10.1016/j.jad.2007.07.002
[9] M. Berk, A. A. Wadee, R. H. Kuschke, et al., “Acute Phase Proteins in Major Depression,” Journal of Psychosomatic Research, Vol. 43, No. 5, 1997, pp. 529-534. doi:10.1016/S0022-3999(97)00139-6
[10] A. Sluzewska, J. Rybakowski, E. Bosmans, et al., “Indicators of Immune Activation in Major Depression,” Psychiatry Research, Vol. 64, No. 3, 1996, pp. 161-167. doi:10.1016/S0165-1781(96)02783-7
[11] A. Reichenberg, R. Yirmiya, A. Schuld, et al., “Cytokine- Associated Emotional and Cognitive Disturbances in Humans,” Archives of General Psychiatry, Vol. 58, 2001, pp. 445-452. doi:10.1001/archpsyc.58.5.445
[12] H. Moshage, “Cytokines and the Hepatic Acute Phase Response,” Journal of Pathology, Vol. 181, No. 3, 1997, pp. 257-266. doi:10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U
[13] E. M. Sternberg, G. P. Chrousos, R. L. Wilder, et al., “The Stress Response and the Regulation of Inflammatory Disease,” Annals of Internal Medicine, Vol. 117, No. 10, 1992, pp. 854-866.
[14] K. S. Lee, J. H. Chung, K. H. Lee, et al., “Simultaneous Measurement of 23 Plasma Cytokines in Late-Life Depression,” Neurological Science, Vol. 30, No. 5, 2009, pp. 435-438. doi:10.1007/s10072-009-0091-1
[15] C. L. Varea, J. E. Castro, H. Sakouhi-Ouertatani, et al., “Macrophage Migration Inhibitory Factor is Critically Involved in Basal and Flouxetine-Stimulated Adult Hypocampal Cell Proliferation and In Anxiety, Depression, and Memory-Related Behaviors,” Molecular Psychiatry, 2010, Epub ahead of Print:
[16] L. Pezawas, A. Meyer-Lindenberg, A. L. Goldman, et al., “Evidence of Biologic Epistasis between BDNF and SLC6A4 and Implications for Depression,” Molecular Psychiatry, Vol. 13, No. 7, 2008, pp. 709-716. doi:10.1038/mp.2008.32
[17] J. R. Hall, S. E. O’Bryant, L. Johnson, et al., “Neuropsychological Performance and Symptoms of Depression,” Scientific Meeting of the International Conference on Alzheimer’s Disease, Honolulu, Hawaii, July 2010.
[18] A. J. Thomas, I. N. Ferrier, R. N. Kalaria, et al., “Evaluation in Late-Life Depression in the Dorsolateral Prefrontal Cortex,” American Journal of Psychiatry, Vol. 157, No. 10, 2000, pp. 1682-1684. doi:10.1176/appi.ajp.157.10.1682
[19] A. J. Thomas, I. N. Ferrier, R. N. Kalaria, S. Davis and J. T. O’Brien, “Cell Adhesion Molecule Expression in the Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex in Major Depression in the Elderly,” British Journal of Psychiatry, Vol. 181, No. 2, 2002, pp. 129-134.
[20] T. Casoli, G. D. Stefano, M. Balietti, et al., “Peripheral Inflammatory Biomarkers of Alzheimer’s disease: The Role of Platelets,” Biogerontology, Vol. 11, No. 5, 2010, pp. 627-633. doi:10.1007/s10522-010-9281-8
[21] A. M. Kulminski, S. V. Ukraintseva, I. V. Kulminskaya, et al., “Cumulative Deficits Better Characterize Susceptibility to Death in Elderly People than Phenotypic Frailty: Lessons from the Cardiovascular Health Study,” Journal of the American Geriatrics Society, Vol. 56, 2008, pp. 898-903. doi:10.1111/j.1532-5415.2008.01656.x
[22] M. Edwards, C. Mauer, J. R. Hall, R. C. Barber and S. E. O’Bryant, “APOE Moderates Link between Affective Status and Cognition: A Project Frontier Study,” The 119th Annual Meeting of the American Psychological Association, Washington D.C., August 2011.
[23] P. Gudmundsson, I. Skoog, M. Waern, et al., “Is There a CSF Biomarker Profile Related to Depression in Elderly Women?” Psychiatry Research, Vol. 176, No. 2-3, 2010, pp. 174-178. doi:10.1016/j.psychres.2008.11.012
[24] N. Andreasen and K. Blennow, “CSF Biomarkers for Mild Cognitive Impairment and Early Alzheimer’s Disease,” Clinical Neurology and Neurosurgery, Vol. 107, No. 3, 2005, pp. 165-173. doi:10.1016/j.clineuro.2004.10.011
[25] M. B. Howren, D. M. Lamkin and J. Suls, “Associations of Depression with C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis,” Psychosomatic Medicine, Vol. 71, No. 2, 2009, pp. 171-186. doi:10.1097/PSY.0b013e3181907c1b
[26] V. Vaccarino, B. D. Johnson, D. S. Sheps, et al., “Depression, Inflammation, and Incident Cardiovascular Disease in Women with Suspected Coronary Ischemia: The National Heart, Lung, and Blood Institute-Sponsored WISE Study,” Journal of the American College of Cardiology, Vol. 50, No. 21, 2007, pp. 2044-2050. doi:10.1016/j.jacc.2007.07.069
[27] S. O’Bryant, J. Hall, K. Cukrowicz, et al., “The Differential Impact of Depressive Symptom Clusters on Cognition in a Rural Multi-Ethnic Cohort: A Project Frontier Study,” International Journal of Geriatric Psychiatry, Vol. 26, No. 2, 2011, pp. 199-205. doi:10.1002/gps.2514
[28] J. A. Yesavage, T. L. Brink, L. R. Terrence, et al., “Development and Validation of a Geriatric Depression Screening Scale: A Preliminary Report,” Journal of Psychiatry Research, Vol. 17, No. 1, 1983, pp. 37-49. doi:10.1016/0022-3956(82)90033-4
[29] S. Waring, S. E. O’Bryant, J. S. Reisch, R. Diaz-Arrastia, J. Knebl and R. Doody, “For the Texas Alzheimer’s Research Consortium. The Texas Alzheimer’s Research Consortium Longitudinal Research Cohort: Study Design and Baseline Characteristics,” Texas Public Health Journal, Vol. 60, No. 3, 2008, pp. 9-13.
[30] J. Hall and T. E. Davis, “Factor Structure of the Geriatric Depression Scale in Cognitive Impaired Older Adults,” Clin Gerontol, Vol. 33, 2010, pp. 39-48. doi:10.1080/07317110903362127
[31] M. Bacher, O. Deuster, B. Aljabari, et al., “The Role of Macrophage Migration Inhibitory Factor in Azheimer’s Disease,” Molecular Medicine, Vol. 16, No. 3-4, 2010, pp. 116-121. doi:10.2119/molmed.2009.00123
[32] M. Piccinelli and G. Wilkinson, “Gender Differences in Depression,” British Journal of Psychiatry, Vol. 177, 2000, pp. 486-492. doi:10.1192/bjp.177.6.486

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.